Just In
Infosys reported Q1 operating margins of 20.8% and secured $3.8 billion in large deals, with 55% being net new
Infosys Q1 FY26 profit rises 9% YoY to ₹6,921 crore, while revenue from operations grows 8% to ₹42,279 crore
Infosys reported Q1 operating margins of 20.8% and secured $3.8 billion in large deals, with 55% being net new
Infosys Q1 FY26 profit rises 9% YoY to ₹6,921 crore, while revenue from operations grows 8% to ₹42,279 crore

cough syrup

(8 search results)

Cough syrup row: Sample testing at designated labs now must for exporters
QP Pharma cough syrup 'duplicated' to defame India: MD
Drug regulator shuts Marion Biotech plant, Uzbek cough syrup death probe on
India's drug regulator probing Uzbekistan cough syrup death allegations
Uzbekistan blames India's Marion Biotech cough syrup for 18 child deaths
The Gambian deadlock: India's drug authority rejects Gambia panel's claim of child deaths from Maiden Pharma drug
Maiden Pharma row: Firm ordered to stop cough syrup production
Probe begins after WHO issues alert for Made in India cough syrup